Literature DB >> 17963167

Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis.

E Solau-Gervais1, F Zerimech, R Lemaire, C Fontaine, G Huet, R-M Flipo.   

Abstract

OBJECTIVE: To compare the activities of cathepsin B (EC 3.4.22.1) and L (EC 3.4.22.15), calpain (EC 3.4.22.17), and dipeptidyl peptidase (EC 3.4.14.5 or DPP IV or CD26) in synovial membrane from patients with rheumatoid arthritis (RA), osteoarthritis (OA), and post-traumatic joint injury (PT).
METHODS: Forty RA patients were divided into two groups on the basis of surgical procedure: the RAs group comprised 18 patients requiring surgical synovectomy; the RAr group comprised 22 patients requiring a total joint replacement or arthrodesis. A third group (the OA group) comprised 19 OA patients while six patients with post-traumatic joint injury were included in the fourth group (the PT group). Cathepsin and calpain activity was assessed using a Cobas Fara II centrifugal analyser. DPP IV activity was determined kinetically using a fluorogenic substrate.
RESULTS: RAs patients were significantly younger than RAr patients, and the mean duration of RA was shorter in the RAs group than in the RAr group. Cathepsin and calpain activity in synovial membrane was higher in RA and OA patients than in the control group, but no statistical difference was observed between RA and OA. However, cathepsin, calpain, and DPP IV synovial activity was significantly higher in the RAs group than in either the OA or the PT group.
CONCLUSION: Our results show that proteinase activity tends to be higher in joints with early synovitis in RA, and suggest that these enzymes are not all involved at the same stage of the disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963167     DOI: 10.1080/03009740701340172

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  18 in total

1.  Serum cysteine proteases and their inhibitors in rheumatoid arthritis: relation to disease activity and radiographic progression.

Authors:  Iben Jørgensen; Janko Kos; Marta Krašovec; Lone Troelsen; Mette Klarlund; Trine W Jensen; Michael S Hansen; Søren Jacobsen
Journal:  Clin Rheumatol       Date:  2010-10-06       Impact factor: 2.980

Review 2.  Cathepsin L targeting in cancer treatment.

Authors:  Dhivya R Sudhan; Dietmar W Siemann
Journal:  Pharmacol Ther       Date:  2015-08-20       Impact factor: 12.310

3.  The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.

Authors:  Elizabeth M Xing; Van W Knox; Patricia A O'Donnell; Tracey Sikura; Yuli Liu; Susan Wu; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

Review 4.  Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis.

Authors:  Leendert A Trouw; Theo Rispens; Rene E M Toes
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

5.  High resistance of the mechanical properties of the chondrocyte pericellular matrix to proteoglycan digestion by chondroitinase, aggrecanase, or hyaluronidase.

Authors:  Rebecca E Wilusz; Farshid Guilak
Journal:  J Mech Behav Biomed Mater       Date:  2013-10-03

6.  Pathogenesis of lumbar spine disease in mucopolysaccharidosis VII.

Authors:  Lachlan J Smith; Guilherme Baldo; Susan Wu; Yuli Liu; Michael P Whyte; Roberto Giugliani; Dawn M Elliott; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2012-03-30       Impact factor: 4.797

Review 7.  The role of dipeptidyl peptidase 4 in hematopoiesis and transplantation.

Authors:  Heather O'Leary; Xuan Ou; Hal E Broxmeyer
Journal:  Curr Opin Hematol       Date:  2013-07       Impact factor: 3.284

Review 8.  Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types.

Authors:  Xuan Ou; Heather A O'Leary; Hal E Broxmeyer
Journal:  Blood       Date:  2013-05-01       Impact factor: 22.113

Review 9.  Counteracting the enzymatic activity of dipeptidylpeptidase 4 for potential therapeutic advantage, with an emphasis on cord blood transplantation.

Authors:  Hal E Broxmeyer
Journal:  Korean J Intern Med       Date:  2013-10-29       Impact factor: 2.884

10.  Gene expression and activity of cartilage degrading glycosidases in human rheumatoid arthritis and osteoarthritis synovial fibroblasts.

Authors:  Mária Pásztói; György Nagy; Pál Géher; Tamás Lakatos; Kálmán Tóth; Károly Wellinger; Péter Pócza; Bence György; Marianna C Holub; Agnes Kittel; Krisztina Pálóczy; Mercédesz Mazán; Péter Nyirkos; András Falus; Edit I Buzas
Journal:  Arthritis Res Ther       Date:  2009-05-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.